ARRAY BIOPHARMA INC's ticker is and the CUSIP is 04269X905. A total of 2 filers reported holding ARRAY BIOPHARMA INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $6,055,000 | +3.7% | 1,307 | -45.4% | 0.02% | +6.2% |
| Q1 2019 | $5,839,000 | +401.6% | 2,395 | +193.1% | 0.02% | +433.3% |
| Q4 2018 | $1,164,000 | -22.9% | 817 | -17.7% | 0.00% | -40.0% |
| Q3 2018 | $1,509,000 | +34.7% | 993 | +48.7% | 0.01% | +25.0% |
| Q2 2018 | $1,120,000 | +956.6% | 668 | +34.4% | 0.00% | -20.0% |
| Q1 2018 | $106,000 | -31.2% | 497 | -35.5% | 0.01% | -28.6% |
| Q4 2017 | $154,000 | -9.4% | 771 | +8.4% | 0.01% | 0.0% |
| Q3 2017 | $170,000 | +4150.0% | 711 | +126.4% | 0.01% | – |
| Q2 2017 | $4,000 | -86.2% | 314 | -35.0% | 0.00% | -100.0% |
| Q1 2017 | $29,000 | -85.4% | 483 | -48.2% | 0.00% | -91.7% |
| Q4 2016 | $198,000 | +76.8% | 933 | +12.1% | 0.01% | +50.0% |
| Q3 2016 | $112,000 | +433.3% | 832 | +149.8% | 0.01% | +700.0% |
| Q2 2016 | $21,000 | +16.7% | 333 | -61.9% | 0.00% | 0.0% |
| Q1 2016 | $18,000 | -30.8% | 874 | -0.8% | 0.00% | -50.0% |
| Q4 2015 | $26,000 | -80.5% | 881 | -46.2% | 0.00% | -80.0% |
| Q3 2015 | $133,000 | +259.5% | 1,638 | +1113.3% | 0.01% | +233.3% |
| Q2 2015 | $37,000 | +1133.3% | 135 | +694.1% | 0.00% | – |
| Q1 2015 | $3,000 | +50.0% | 17 | +70.0% | 0.00% | – |
| Q4 2014 | $2,000 | – | 10 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 274,200 | $1,157,000 | 0.01% |
| SIMPLEX TRADING, LLC | 881 | $26,000 | 0.00% |
| Citadel Advisors | 40,100 | $169,000 | 0.00% |